SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Johannesson Magnus)
 

Sökning: WFRF:(Johannesson Magnus) > Advantages of using...

Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies

Johannesson, Magnus (författare)
Stockholm School of Economics,Handelshögskolan i Stockholm
Jönsson, Bengt (författare)
Stockholm School of Economics,Handelshögskolan i Stockholm
Löthgren, Michael (författare)
Eli Lilly European Health Outcomes Research, Windlesham, United Kingdom
visa fler...
Tambour, Magnus (författare)
Wyeth Lederle Nordiska AB, Solna, Sweden
Zethraeus, Niklas (författare)
Stockholm School of Economics,Handelshögskolan i Stockholm
visa färre...
 (creator_code:org_t)
Adis International, 2003
2003
Engelska.
Ingår i: PharmacoEconomics. - : Adis International. - 1179-2027 .- 1170-7690. ; 21:1, s. 39-48
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • No consensus has yet been reached on how to analyse uncertainty in economic evaluation studies where individual patient data are available for costs and health effects. This paper summarises the available results regarding the analysis of uncertainty on the cost-effectiveness plane and argues for using the net-benefit approach when analysing uncertainty in cost-effectiveness studies. The net-benefit approach avoids the interpretation and statistical problems related to the incremental cost effectiveness ratio and implies several advantages. First, traditional statistical methods can be used for confidence-interval estimation and hypothesis testing. Second, calculation of the optimal sample size and the power of the study are facilitated allowing the correlation between costs and effects to vary within and between patient groups. Third, the use of a Bayesian approach to cost-effectiveness analysis is facilitated. Fourth, a formal relation between cost-effectiveness acceptability curves and statistical inference is provided. Finally, the net-benefit approach gives the Fieller's limits of the confidence interval for the incremental cost-effectiveness ratio in the cost-effectiveness plane. Based on these advantages the net-benefit approach should strongly be considered when analysing uncertainty in cost-effectiveness analyses.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Health Care Service and Management, Health Policy and Services and Health Economy (hsv//eng)

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy